UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Epidemiology and overall survival of gastric carcinoma patients (about 210 cases) experience of medical oncology department of CHU Hassan II Fez

Annals of oncology, 2018-06, Vol.29, p.v3-v3

2018

Volltextzugriff (PDF)

Prognostic value of neo-adjuvant treatment in localized rectal cancer about 78 cases

Annals of oncology, 2018-06, Vol.29, p.v57-v57

2018

Volltextzugriff (PDF)

Survival and prognostic factors of non metastatic rectal adenocarcinoma: Analytic multifactor review of 91 cases

Annals of oncology, 2018-06, Vol.29, p.v56-v57

2018

Volltextzugriff (PDF)

EP15.03-03 Assessment of the Multidisciplinary Onco-thoracic Consultation Meeting of the University Hospital Center of Tangier

Journal of thoracic oncology, 2023-11, Vol.18 (11), p.S730

2023

Volltextzugriff (PDF)

Targeting HER2: current place of trastuzumab-deruxtecan

Revue médicale de Bruxelles, 2024, Vol.45 (2), p.141-144

2024

Volltextzugriff (PDF)

P-009Epidemiology and overall survival of gastric carcinoma patients (about 210 cases) experience of medical oncology department of CHU Hassan II Fez

Annals of oncology, 2018-06, Vol.29 (suppl_5)

2018

Volltextzugriff (PDF)

50P The difficulties associated with handling bone sarcoma in the northern region of Morocco

ESMO open, 2024-03, Vol.9, p.102561, Article 102561

2024

Volltextzugriff (PDF)

P-204Prognostic value of neo-adjuvant treatment in localized rectal cancer about 78 cases

Annals of oncology, 2018-06, Vol.29 (suppl_5)

2018

Volltextzugriff (PDF)

P-203Survival and prognostic factors of non metastatic rectal adenocarcinoma: Analytic multifactor review of 91 cases

Annals of oncology, 2018-06, Vol.29 (suppl_5)

2018

Volltextzugriff (PDF)

Case study of marine pollution in Teluk Bahang, Penang, Malaysia

IOP conference series. Earth and environmental science, 2020-01, Vol.414 (1), p.12032

2020

Volltextzugriff (PDF)

Final Overall Survival Analysis of the TOURMALINE-MM1 Phase III Trial of Ixazomib, Lenalidomide, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma

Journal of clinical oncology, 2021-08, Vol.39 (22), p.2430-2442

2021

Volltextzugriff (PDF)

Academic stress and burnout among primary school trainee teachers in the Rabat-Sale-Kenitra region

E3S Web of Conferences, 2021, Vol.319, p.1029

2021

Volltextzugriff (PDF)

Distinctive roles of PKC delta isozyme in platelet function

Current research in translational medicine, 2016-07, Vol.64 (3), p.135-139

2016

Volltextzugriff (PDF)

Clinical Results and Biomarker Analyses of Axitinib and TRC105 versus Axitinib Alone in Patients with Advanced or Metastatic Renal Cell Carcinoma (TRAXAR)

The oncologist (Dayton, Ohio), 2021-07, Vol.26 (7), p.560-e1103

2021

Volltextzugriff (PDF)

Relationship of time to metastasis (TTM) and site of metastases in patients (pts) with nonmetastatic castration-resistant prostate cancer (nmCRPC): Results from the phase 3 SPARTAN trial

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.5033-5033

2018

Volltextzugriff (PDF)

Validation of Academic burnout scale among Moroccan trainee teachers

E3S Web of Conferences, 2021, Vol.319, p.2026

2021

Volltextzugriff (PDF)

Noise pollution at school environment: review study of China and South Africa cases

E3S Web of Conferences, 2021, Vol.319, p.2006

2021

Volltextzugriff (PDF)

912PDResults of the phase II TRAXAR study: A randomized phase II trial of axitinib and TRC105 (TRAX) versus axitinib (AX) alone in patients with advanced or metastatic renal cell carcinoma (mRCC)

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

Predicting disease progression in patients (pts) with nonmetastatic castration-resistant prostate cancer (nmCRPC): An analysis from the phase 3 SPARTAN trial

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.5034-5034

2018

Volltextzugriff (PDF)

TITAN: A randomized, double-blind, placebo-controlled, phase 3 trial of apalutamide (ARN-509) plus androgen deprivation therapy (ADT) in metastatic hormone-sensitive prostate cancer (mHSPC)

Annals of oncology, 2016-10, Vol.27, p.vi265-vi265

2016

Volltextzugriff (PDF)

An integrated analysis of thirteen trials summarizing the long-term safety of alefacept in psoriasis patients who have received up to nine courses of therapy

Clinical therapeutics, 2005-12, Vol.27 (12), p.1912-1921

2005

Volltextzugriff (PDF)

Treatment with yttrium 90 ibritumomab tiuxetan at early relapse is safe and effective in patients with previously treated B-cell non-Hodgkin's lymphoma

Leukemia & lymphoma, 2006-04, Vol.47 (4), p.629-636

2006

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(33)

Publikationsform

Sprache

Englisch
(36)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(11)
Science & Technology
(11)
Humans
(9)
Female
(6)
Male
(6)
Middle Aged
(6)
Oncology
(6)
Aged
(5)
Adult
(4)
Aged, 80 And Over
(3)
Hematology
(3)
Lymphoma, B-Cell - Drug Therapy
(3)
Adolescent
(2)
Animals
(2)
Antibodies, Monoclonal - Therapeutic Use
(2)
Antineoplastic Agents - Therapeutic Use
(2)
Biological And Medical Sciences
(2)
Burnout
(2)
Clinical Trials As Topic
(2)
Follow-Up Studies
(2)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Epidemiology and overall survival of gastric carcinoma patients (about 210 cases) experience of medical oncology department of CHU Hassan II Fez

Prognostic value of neo-adjuvant treatment in localized rectal cancer about 78 cases

Survival and prognostic factors of non metastatic rectal adenocarcinoma: Analytic multifactor review of 91 cases

EP15.03-03 Assessment of the Multidisciplinary Onco-thoracic Consultation Meeting of the University Hospital Center of Tangier

Targeting HER2: current place of trastuzumab-deruxtecan

P-009Epidemiology and overall survival of gastric carcinoma patients (about 210 cases) experience of medical oncology department of CHU Hassan II Fez

50P The difficulties associated with handling bone sarcoma in the northern region of Morocco

P-204Prognostic value of neo-adjuvant treatment in localized rectal cancer about 78 cases

P-203Survival and prognostic factors of non metastatic rectal adenocarcinoma: Analytic multifactor review of 91 cases

Case study of marine pollution in Teluk Bahang, Penang, Malaysia

Final Overall Survival Analysis of the TOURMALINE-MM1 Phase III Trial of Ixazomib, Lenalidomide, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma

Academic stress and burnout among primary school trainee teachers in the Rabat-Sale-Kenitra region

Distinctive roles of PKC delta isozyme in platelet function

Clinical Results and Biomarker Analyses of Axitinib and TRC105 versus Axitinib Alone in Patients with Advanced or Metastatic Renal Cell Carcinoma (TRAXAR)

Relationship of time to metastasis (TTM) and site of metastases in patients (pts) with nonmetastatic castration-resistant prostate cancer (nmCRPC): Results from the phase 3 SPARTAN trial

Prognostic risk score for patients with relapsed or refractory chronic lymphocytic leukaemia treated with targeted therapies or chemoimmunotherapy: a retrospective, pooled cohort study with external validations

Validation of Academic burnout scale among Moroccan trainee teachers

Noise pollution at school environment: review study of China and South Africa cases

912PDResults of the phase II TRAXAR study: A randomized phase II trial of axitinib and TRC105 (TRAX) versus axitinib (AX) alone in patients with advanced or metastatic renal cell carcinoma (mRCC)

Predicting disease progression in patients (pts) with nonmetastatic castration-resistant prostate cancer (nmCRPC): An analysis from the phase 3 SPARTAN trial

Risk Model for Overall Survival for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia: Validated for Patients on Ibrutinib, Idelalisib, Venetoclax, or Chemoimmunotherapy

TITAN: A randomized, double-blind, placebo-controlled, phase 3 trial of apalutamide (ARN-509) plus androgen deprivation therapy (ADT) in metastatic hormone-sensitive prostate cancer (mHSPC)

A Validated Risk Model for Overall Survival in Relapsed/Refractory Chronic Lymphocytic Leukemia Applicable to Patients Treated with Novel Therapies and Standard of Care

An integrated analysis of thirteen trials summarizing the long-term safety of alefacept in psoriasis patients who have received up to nine courses of therapy

Treatment with yttrium 90 ibritumomab tiuxetan at early relapse is safe and effective in patients with previously treated B-cell non-Hodgkin's lymphoma

Suchergebnisse filtern